Coronavirus
To visit the Select Subcommittee on the Coronavirus Crisis, click here.
In light of the ongoing Coronavirus crisis, the Committee on Oversight and Reform has been conducting oversight of our nation's preparedness for, and response to, the outbreak. The Committee's top priority is promoting the health and safety of the American people, and the information below is from the Committee's investigative activities, the Centers for Disease Control and Prevention (CDC), and other sources.
Oversight Committee Hearing Mentioned on NBC's Meet the Press, March 15, 2020:
Full Committee Activities:
More on Coronavirus
Washington, D.C. (May 19, 2021)—Below is Committee on Oversight and Reform Chairwoman Carolyn B. Maloney's opening statement, as prepared for delivery, for today's hybrid hearing with Emergent BioSolutions' executives.
Washington, D.C. (May 19, 2021) —Rep. James E. Clyburn, Chairman of the Select Subcommittee on the Coronavirus Crisis, delivered the following opening statement at today's hybrid hearing with Mr. Robert Kramer, President and Chief Executive Officer of Emergent BioSolutions, Inc. (Emergent), and Mr. Fuad El-Hibri, Executive Chairman of Emergent:
Washington, D.C. (May 19, 2021) — Today, Rep. James E. Clyburn, Chairman of the Select Subcommittee on the Coronavirus Crisis, and Rep. Carolyn B.
Washington, D.C. (May 11, 2021) — Today, Rep. James E. Clyburn, Chairman of the Select Subcommittee on the Coronavirus Crisis, and Rep.
Washington, D.C. (May 10, 2021)—Today, Rep. Carolyn B. Maloney, the Chairwoman of the Committee on Oversight and Reform, issued this statement following the announcement that the Treasury Department will soon begin releasing $350 billion of critical funding for states and localities that was passed by Congress in the American Rescue Plan Act of 2021:
| Washington, D.C. (April 19, 2021)—Today, Rep. Carolyn B. Maloney, Chairwoman of the House Committee on Oversight and Reform, and Rep. James E. |
Washington D.C. (April 9, 2021)—Today, Chairman James E. Clyburn sent letters to three Trump Administration advisors—Dr. Scott Atlas, Dr.